Design Therapeutics, Inc.

10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Results of operations (earnings release) Aug 3, 2026 8-K Shareholder vote results Jun 11, 2026 8-K Other events May 18, 2026 10-Q Quarter ended 2026-03-31 Apr 28, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Apr 28, 2026 8-K Director or officer change Apr 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 9, 2026 8-K Results of operations (earnings release) Mar 9, 2026 8-K Director or officer change Jan 30, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Director or officer change Sep 10, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 7, 2025 8-K Shareholder vote results Jun 12, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 10, 2025 8-K Results of operations (earnings release) Mar 10, 2025 8-K Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 5, 2024 8-K Results of operations (earnings release) Aug 5, 2024 8-K Shareholder vote results Jun 17, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 10-K Fiscal year ended 2023-12-31 Mar 19, 2024 8-K Results of operations (earnings release) Mar 19, 2024 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Results of operations (earnings release) Nov 13, 2023 8-K Director or officer change Aug 25, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Results of operations (earnings release) Aug 14, 2023 8-K Shareholder vote results Jun 1, 2023 10-Q Quarter ended 2023-03-31 May 9, 2023 8-K Results of operations (earnings release) May 9, 2023 10-K Fiscal year ended 2022-12-31 Mar 14, 2023 8-K Results of operations (earnings release) Mar 14, 2023